skip to main content
Resultados 1 2 3 4 next page
Mostrar Somente
Refinado por: assunto: Adult remover assunto: Aged remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Are SSRI antidepressants a clinically homogeneous class of compounds?
Material Type:
Artigo
Adicionar ao Meu Espaço

Are SSRI antidepressants a clinically homogeneous class of compounds?

Sacchetti, E. ; Conte, G. ; Guarneri, L.

The Lancet (British edition), 1994-07, Vol.344 (8915), p.126-127 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

2
Plasma concentrations of the enantiomers of fluoxetine and norfluoxetine: Sources of variability and preliminary observations on relations with clinical response
Material Type:
Artigo
Adicionar ao Meu Espaço

Plasma concentrations of the enantiomers of fluoxetine and norfluoxetine: Sources of variability and preliminary observations on relations with clinical response

JANNUZZI, Giovanna ; GATTI, Giuliana ; MAGNI, Paolo ; SPINA, Edoardo ; PACIFICI, Roberta ; ZUCCARO, Piergiorgio ; TORTA, Riccardo ; GUARNERI, Laura ; PERUCCA, Emilio

Therapeutic drug monitoring, 2002-10, Vol.24 (5), p.616-627 [Periódico revisado por pares]

Hagerstown, MD: Lippincott Williams & Wilkins

Texto completo disponível

3
Integrated evaluation of PAM50 subtypes and immune modulation of pCR in HER2-positive breast cancer patients treated with chemotherapy and HER2-targeted agents in the CherLOB trial
Material Type:
Artigo
Adicionar ao Meu Espaço

Integrated evaluation of PAM50 subtypes and immune modulation of pCR in HER2-positive breast cancer patients treated with chemotherapy and HER2-targeted agents in the CherLOB trial

Dieci, M.V. ; Prat, A. ; Tagliafico, E. ; Paré, L. ; Ficarra, G. ; Bisagni, G. ; Piacentini, F. ; Generali, D.G. ; Conte, P. ; Guarneri, V.

Annals of oncology, 2016-10, Vol.27 (10), p.1867-1873 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

4
Association of tumor-infiltrating lymphocytes with distant disease-free survival in the ShortHER randomized adjuvant trial for patients with early HER2+ breast cancer
Material Type:
Artigo
Adicionar ao Meu Espaço

Association of tumor-infiltrating lymphocytes with distant disease-free survival in the ShortHER randomized adjuvant trial for patients with early HER2+ breast cancer

Dieci, M.V. ; Conte, P. ; Bisagni, G. ; Brandes, A.A. ; Frassoldati, A. ; Cavanna, L. ; Musolino, A. ; Giotta, F. ; Rimanti, A. ; Garrone, O. ; Bertone, E. ; Cagossi, K. ; Sarti, S. ; Ferro, A. ; Piacentini, F. ; Maiorana, A. ; Orvieto, E. ; Sanders, M. ; Miglietta, F. ; Balduzzi, S. ; D’Amico, R. ; Guarneri, V.

Annals of oncology, 2019-03, Vol.30 (3), p.418-423 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

5
Dupilumab therapy of atopic dermatitis of the elderly: a multicentre, real‐life study
Material Type:
Artigo
Adicionar ao Meu Espaço

Dupilumab therapy of atopic dermatitis of the elderly: a multicentre, real‐life study

Patruno, C. ; Napolitano, M. ; Argenziano, G. ; Peris, K. ; Ortoncelli, M. ; Girolomoni, G. ; Offidani, A. ; Ferrucci, S.M. ; Amoruso, G.F. ; Rossi, M. ; Stingeni, L. ; Malara, G. ; Grieco, T. ; Foti, C. ; Gattoni, M. ; Loi, C. ; Iannone, M. ; Talamonti, M. ; Stinco, G. ; Rongioletti, F. ; Pigatto, P.D. ; Cristaudo, A. ; Nettis, E. ; Corazza, M. ; Guarneri, F. ; Amerio, P. ; Esposito, M. ; Belloni Fortina, A. ; Potenza, C. ; Fabbrocini, G. ; Angileri, L. ; Bianchelli, T. ; Borghi, A. ; Buligan, C. ; Calabrese, G. ; Calzavara Pinton, P. ; Caroppo, F. ; Chello, C. ; Dal Bello, G. ; Damiani, G. ; Fargnoli, M.C. ; Ferrillo, M. ; Galluzzo, M. ; Gori, N. ; Gualdi, G. ; Hansel, K. ; Macchia, L. ; Mariano, M. ; Nisticò, S.P. ; Pertusi, G. ; Piras, V. ; Provenzano, E. ; Ravaioli, G.M. ; Ribero, S. ; Romanelli, M. ; Romita, P. ; Tolino, E. ; Trifirò, C.

Journal of the European Academy of Dermatology and Venereology, 2021-04, Vol.35 (4), p.958-964 [Periódico revisado por pares]

England

Texto completo disponível

6
Frequency and Risk Factors Associated With Osteonecrosis of the Jaw in Cancer Patients Treated With Intravenous Bisphosphonates
Material Type:
Artigo
Adicionar ao Meu Espaço

Frequency and Risk Factors Associated With Osteonecrosis of the Jaw in Cancer Patients Treated With Intravenous Bisphosphonates

Hoff, Ana O ; Toth, Béla B ; Altundag, Kadri ; Johnson, Marcella M ; Warneke, Carla L ; Hu, Mimi ; Nooka, Ajay ; Sayegh, Gilbert ; Guarneri, Valentina ; Desrouleaux, Kimberly ; Cui, Jeffrey ; Adamus, Andrea ; Gagel, Robert F ; Hortobagyi, Gabriel N

Journal of bone and mineral research, 2008-06, Vol.23 (6), p.826-836 [Periódico revisado por pares]

Washington, DC: John Wiley and Sons and The American Society for Bone and Mineral Research (ASBMR)

Texto completo disponível

7
Social distress among medical oncologists and other healthcare professionals during the first wave of COVID-19 pandemic in Italy
Material Type:
Artigo
Adicionar ao Meu Espaço

Social distress among medical oncologists and other healthcare professionals during the first wave of COVID-19 pandemic in Italy

Berardi, R. ; Torniai, M. ; Cona, M.S. ; Cecere, F.L. ; Chiari, R. ; Guarneri, V. ; La Verde, N. ; Locati, L. ; Lorusso, D. ; Martinelli, E. ; Giannarelli, D. ; Garassino, M.C.

ESMO open, 2021-04, Vol.6 (2), p.100053-100053, Article 100053 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

8
Preclinical atherosclerosis and metabolic syndrome increase cardio- and cerebrovascular events rate: a 20-year follow up
Material Type:
Artigo
Adicionar ao Meu Espaço

Preclinical atherosclerosis and metabolic syndrome increase cardio- and cerebrovascular events rate: a 20-year follow up

Novo, Salvatore ; Peritore, Angelica ; Trovato, Rosaria Linda ; Guarneri, Francesco Paolo ; Di Lisi, Daniela ; Muratori, Ida ; Novo, Giuseppina

Cardiovascular diabetology, 2013-10, Vol.12 (1), p.155-155 [Periódico revisado por pares]

England: BioMed Central

Texto completo disponível

9
Nine weeks versus 1 year adjuvant trastuzumab in combination with chemotherapy: final results of the phase III randomized Short-HER study
Material Type:
Artigo
Adicionar ao Meu Espaço

Nine weeks versus 1 year adjuvant trastuzumab in combination with chemotherapy: final results of the phase III randomized Short-HER study

Conte, P. ; Frassoldati, A. ; Bisagni, G. ; Brandes, A.A. ; Donadio, M. ; Garrone, O. ; Piacentini, F. ; Cavanna, L. ; Giotta, F. ; Aieta, M. ; Gebbia, V. ; Molino, A. ; Musolino, A. ; Ferro, A. ; Maltoni, R. ; Danese, S. ; Zamagni, C. ; Rimanti, A. ; Cagossi, K. ; Russo, A. ; Pronzato, P. ; Giovanardi, F. ; Moretti, G. ; Lombardo, L. ; Schirone, A. ; Beano, A. ; Amaducci, L. ; Bajardi, E.A. ; Vicini, R. ; Balduzzi, S. ; D’Amico, R. ; Guarneri, V.

Annals of oncology, 2018-12, Vol.29 (12), p.2328-2333 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

10
Immunoglobulin G fragment C receptor polymorphisms and efficacy of preoperative chemotherapy plus trastuzumab and lapatinib in HER2-positive breast cancer
Material Type:
Artigo
Adicionar ao Meu Espaço

Immunoglobulin G fragment C receptor polymorphisms and efficacy of preoperative chemotherapy plus trastuzumab and lapatinib in HER2-positive breast cancer

Musolino, A ; Naldi, N ; Dieci, M V ; Zanoni, D ; Rimanti, A ; Boggiani, D ; Sgargi, P ; Generali, D G ; Piacentini, F ; Ambroggi, M ; Cagossi, K ; Gianni, L ; Sarti, S ; Bisagni, G ; Ardizzoni, A ; Conte, P F ; Guarneri, V

The pharmacogenomics journal, 2016-10, Vol.16 (5), p.472-477 [Periódico revisado por pares]

United States: Nature Publishing Group

Texto completo disponível

Resultados 1 2 3 4 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (31)

Data de Publicação 

De até
  1. Antes de1994  (4)
  2. 1994Até2000  (5)
  3. 2001Até2007  (5)
  4. 2008Até2015  (7)
  5. Após 2015  (12)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (31)
  2. Japonês  (3)
  3. Italiano  (1)
  4. Mais opções open sub menu

Buscando em bases de dados remotas. Favor aguardar.